1 / 2

Survie globale en ITT

Survie globale en ITT. 1,0. 0,8. 0,6. Placebo. 0,4. 0,2. Vaccin. p = 0,594 HR = 0,94. 0. 0. 6. 12. 18. 24. 30. 36. 42. 48. 54. ESMO 2013 – D’après Giaccone G et al., LBA 2, actualisé. Mois. Survie des patients randomisés dans les 12 semaines.

ghalib
Download Presentation

Survie globale en ITT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Survie globale en ITT 1,0 0,8 0,6 Placebo 0,4 0,2 Vaccin p = 0,594HR = 0,94 0 0 6 12 18 24 30 36 42 48 54 • ESMO 2013 – D’après Giaccone G et al., LBA 2, actualisé Mois

  2. Survie des patients randomisés dans les 12 semaines Tous les patients inclus dans les 12 semainessuivant la chimiothérapie Patients de stade IIIB/IV inclus dans les 12 semaines suivant la chimiothérapie 1,0 1,0 0,8 0,8 0,6 0,6 Vaccin 0,4 0,4 Vaccin 0,2 0,2 p = 0,092HR = 0,77 p = 0,083HR = 0,75 Placebo Placebo 0 0 0 6 12 18 24 30 36 42 48 54 0 6 12 18 24 30 36 42 48 54 Mois Mois • ESMO 2013 – D’après Giaccone G et al., LBA 2, actualisé

More Related